Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Event Highlights

Immerse yourself in the latest information, approaches and successes from industry

Introducing this year’s BRAND NEW conference...

Day One - 28th February 2018
  • How did Novartis win the CAR-T race in Europe?
  • What are the updates for the use of CAR-T therapies when it comes to solid tumours?
  • What can the EU/US and Asia learn from each other?
  • What biodegradable microcarriers are there for stem cell production and tissue implantation?
  • How can in process monitoring be used as part of a closed-cell culture system?
  • A closer look at expansion cell culture and cost saving and safety considerations
  • What are the best methods for conducting cost of goods calculations for cell therapy products?
Day Two - 1st March 2018
  • What are the regulatory and development status’ in both China and Taiwan?
  • The conditional and time-limited approval systems for new regenerative medicine in Japan
  • What considerations are there when taking allogeneic T cell therapies from bench to bedside?
  • How can you develop serum free culture conditions for CAR-T cell expansion?
  • What are the best methods for choosing your development partner?
  • What capabilities should your CDMO have?
  • How do you alleviate bottlenecks with regards to transportation strategies from manufacture to patient?
Additional Learning Opportunities


Tuesday 27th February - Comparability Testing for ATMPs

  • Introduction to comparability
  • Regulatory framework
  • Process and product characterisation
  • Comparability expectations during clinical development and post-approval
  • Examples of changes and comparability strategies and Case study exercise

Friday 2nd March  - Understanding Potency and Developing Potency Assays for ATMPs

Both workshops will be led by: Christopher Bravery, Consulting on Advanced Biologicals Ltd., Member, ISCT EU Legal and Regulatory Affairs Committee, UK